Comparison of lipid measures and risk stratification among end-stage renal disease patients

Journal of Nephrology

Volumn 20, Issue 2, 2007, Pages 212-218

  Bowden, Rodney G ^a   Hebert, Stuart ^a   Wilson, Ronald ^b   Gentile, Mindy ^c   Lanning, Beth A ^a  

^a BAYLOR UNIVERSITY   (United States)

^b Central Texas Nephrology Associates   (United States)

^c Brazos Kidney Center   (United States)

Author keywords

ATP III; Cholesterol; HDL; HDL particle number; HDL size; LDL; LDL particle number; LDL size; NCEP; NMR

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; FEMALE; GEL ELECTROPHORESIS; HUMAN; KIDNEY FAILURE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; RISK FACTOR; SPECTROSCOPY;

AGED; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; FEMALE; GUIDELINES; HEALTH EDUCATION; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PARTICLE SIZE; RENAL DIALYSIS; RISK ASSESSMENT;

EID: 34447513265     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alabakovask SB, Todorova BB, Labudovic DD, Tosheska KN. LDL and HDL subclass distribution in patients with end-stage renal diseases. Clin Biochem 2002; 35: 211-6.
2. Koutoubi S, Huffman FG. Serum total homocysteine levels, folate, and B-vitamins intake and coronary heart disease risk factors among tri-ethnic college students. Ethn Dis 2004; 14: 64-72.
3. Bowden FIG, Kingery PM, Rust D. Assessing risk using different cholesterol measures. Public Health 2004; 118: 225-9.
4. National Institutes of Health. Report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Washington DC: US Government Printing Office 1989.
5. Tavares EF, Vieira-Filho JP, Andriolo A, Perez AB, Vergani N, Sañudo A, Gimeno SG, Franco LJ. Risk factors for heart disease. Ethn Dis 2004; 14: 159.
6. Bowden RG, Kingery PM. Significant predictors of elevated cholesterol in a worksite screening program. Journal of Academic Inquiries 2004; 1: 2-13.
7. Bowden RG, Kingery P, Brizzolara J. Prediction accuracy and contrast of three dichotomous cholesterol measures. J Health Educ 1999; 30: 284-9.
8. National Institutes of Health. Report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: third report. Washington DC: US Government Printing Office 2002.
9. Osgood D, Corella D, Demissle S, Cupples LA, Wilson PW, Meigs JB, Schaefer EJ, Coltell O, Ordovas JM. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the Framingham study. J Clin Endocrinol Metab 2003; 88: 2869-79.
10. Scheffer PG, Bos G, Volwater HG, Dekker JM, Heine RJ, Teerlink T. Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients. Diabet Med 2003; 20: 563-8.
11. Lamarche B, Lemieux I, Despres JR The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999; 25: 199-211.
12. Otvos J, Jeyarajah E, Cromwell W. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 2002; 90 (Suppl): 22i-29i.
13. Goff DC, D'Agostino RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations: results from the insulin Resistance Atherosclerosis Study. Metab Clin Exp 2005; 54: 264-70.
14. Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvery WT, Klein RL; the DCCT/EDIC Research Group. Lipoproteins in the DCCT/ EDIC cohort: associations with diabetic nephropathy. Kidney Int 2003, 64: 817-28.
15. Soedamah-Muthu SS, Change YF, Otvos J, Evans RW, Orchard TJ. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type I diabetics: a prospective report from the Pittsburg Epidemiology of Diabetes Complications study. Diabetologia 2003; 46: 674-82.
16. Garvey T Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by NMR. Diabetes 2003; 52: 453-62.
17. Sjogren P, Rosell M, Skoglund-Andersson C, Zdravkovic S, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J Nutr 2004; 134: 1729-35.
18. Ito Y, Hirano T, Yamazaki J, Yoshino G. New simple method for small, dense LDL: development of a new quantification method and clinical significance. Rinsho Byori 2004; 52: 406-13.
19. Iseki K. Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002; 61: 1887-93.
20. Lee P Murphy B, O'Neal D, Best J. High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis. Aust N Z J Med 1997; 3: 285-93.
21. Maruyama C, Imamura K, Teramoto T Assessment of LDL particle size by trigyleride/HDL-cholesterol ratio in non-diabetic, healthy subjects with prominent hyperlipidemia. J Atheroscler Thromb 2003; 10: 186-91.
22. Yang Y. Yan B, Fu M, Xu Y, Tian Y. Relationship between plasma lipid concentrations and HDL subclasses. Clin Chim Acta 2005; 354: 49-58.